NeuroOne Medical Technologies Corporation - Common Stock (NMTC)
1.0700
+0.0700 (7.00%)
NASDAQ · Last Trade: Oct 7th, 2:48 PM EDT
Detailed Quote
Previous Close
1.000
Open
1.080
Bid
1.060
Ask
1.070
Day's Range
1.020 - 1.160
52 Week Range
0.3954 - 1.390
Volume
1,088,052
Market Cap
12.84M
PE Ratio (TTM)
-7.133
EPS (TTM)
-0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
488,973
Chart
About NeuroOne Medical Technologies Corporation - Common Stock (NMTC)
Neuroone Medical Technologies Corp is a pioneering medical technology company focused on developing innovative solutions for neurological disorders. The company specializes in creating advanced devices and technologies aimed at improving the diagnosis and treatment of conditions such as epilepsy, Parkinson's disease, and chronic pain. Neuroone's offerings include breakthrough electrode systems that facilitate precise brain interaction, enabling better therapeutic outcomes. Through their commitment to research and development, Neuroone seeks to address critical healthcare needs in the neurology field while enhancing patients' quality of life. Read More
EDEN PRAIRIE, MINN. - October 6, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced preliminary unaudited product revenue for the fiscal year ended September 30, 2025.
EDEN PRAIRIE, MINN. - September 29, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations, recent FDA clearance and corporate updates.
NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
